pharma news

News

Novartis has claimed a first-in-class approval in the US for its oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria.

News

The US government has shut down after Republicans and Democrats failed to resolve a budget standoff and the federal government ran out of money.

News

At the White House today, President Trump and Pfizer CEO Albert Bourla announced the first of many deals to secure MFN drug prices for US consumers.

News

A phase 3 trial of Vertanical's cannabis extract in back pain has been published, and the results bode well for marketing applications under review.

News

A new £1.2 billion science and technology park was formally opened today in Oxford, in a welcome boost to the UK's life sciences sector.

News

The UK says a new online NHS hospital service due to start in 2027 will deliver up to 8.5m extra NHS appointments in its first three years.